Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| René Vleugels | M | - |
CyTuVax BV
 CyTuVax BV Pharmaceuticals: MajorHealth Technology CyTuVax BV develops vaccinations for cancer treatment. Its vaccination technology includes an adjuvant composed of depot-bound cytokines acting as immune response modifiers. The firm also provides adjuvant technology licensing services. The company was founded by René Vleugels and Frank W. Falkenberg in 2011 and is headquartered in Maastricht, the Netherlands. | 13 years |
See more
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| Netherlands | 1 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Frank W. Falkenberg
- Personal Network
